The eczema therapeutics market will witness a neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio's pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020.
Key Considerations for Market Forecast:
- Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
- Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
- Pre- as well as post-COVID-19 market estimates
- Quarterly impact analysis and updates on market estimates
Major Five Eczema Therapeutics Market Participants:
AbbVie Inc.: The company offers eczema therapeutics under the brand name RINVOQ.
Alliance Pharma Plc: The company offers eczema therapeutics under the brand name Hydromol.
Bausch Health Companies Inc.: The company offers eczema therapeutics under the brand name DUOBRII Lotion.
Bayer AG: The company offers eczema therapeutics under the brand names Bepanthen and Canesten.
Eli Lilly and Co.: The company offers eczema therapeutics under the brand name OLUMIANT.
Eczema Therapeutics Market 2021-2025: Segmentation
Eczema therapeutics market is segmented as below:
- Geography
- North America
- Europe
- Asia
- ROW
- Indication
- Atopic Dermatitis
- Contact Dermatitis
- Others
The eczema therapeutics market is driven by the high prevalence of atopic dermatitis, strong pipeline landscape, and increasing product launches. In addition, other factors such as increasing healthcare expenditure and geopolitical uncertainties are expected to trigger the eczema therapeutics market toward witnessing a CAGR of over 9% during the forecast period.
Get more insights into the global trends impacting the future of the eczema therapeutics market.
Request Free Sample @ https://www.technavio.com/talk-to-us?report=IRTNTR40707
Related Reports on Healthcare Include:
Global Allergy Immunotherapies Market - Global allergy immunotherapies market is segmented by product (SCIT and SLIT) and geography (Europe, North America, Asia, and ROW).
Download Exclusive Free Sample Report
Global Allergy Rhinitis Drugs Market - Global allergy rhinitis drugs market is segmented by product (antihistamines, intranasal corticosteroids, immunotherapies, and others) and geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Gain instant access to 17,000+ market research reports by using
Technavio's SUBSCRIPTION platform
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Report: www.technavio.com/report/eczema-therapeutics-market-industry-analysis
SOURCE Technavio
Share this article